# Micro-nanoplastic Exposure and Coronary Microcirculatory Dysfunction as Well as Cardiovascular Outcomes

> **NCT07748767** · — · NOT_YET_RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 184 (estimated)

## Conditions studied

- Coronary Microvascular Dysfunction (CMD)
- Microplastic Exposure
- Nanoplastics
- MACE

## Interventions

- **OTHER:** micro-nanoplastic examination
- **PROCEDURE:** Microvascular Function Examination

## Key facts

- **NCT ID:** NCT07748767
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748767, "Micro-nanoplastic Exposure and Coronary Microcirculatory Dysfunction as Well as Cardiovascular Outcomes". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07748767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*